Mesoblast | MSB - EPS Earnings Per Share

Stock Price
2.09
Daily Change
0 0%
Monthly
3.47%
Yearly
19.77%
Q2 Forecast
2.16

Mesoblast reported $-0.03 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026H2 Jun/2026 -0.01 -0.04 May/29
FY2025H2 Jun/2025 -0.04 -0.04 -41273000.0000 Aug/28
FY2025H1 Dec/2024 -0.04 -0.02 -0.02 Feb/26
FY2024H2 Jun/2024 -0.03 -0.05 Aug/28
FY2024H1 Dec/2023 -0.02 -0.02 -0.06 Feb/28




Eps Change Date
Avita Medical AUD -0.38 0 Dec/2025
Clinuvel Pharmaceuticals AUD 0.21 0.23 Dec/2025
Cochlear AUD 3.13 0.25 Dec/2025
CSL USD 5.07 3 Dec/2025
Pacific Edge NZD -0.02 0 Dec/2025
Paradigm Biopharmaceuticals AUD -0.06 0.03 Dec/2025
PYC Therapeutics AUD -0.04 0.01 Dec/2025
Ramsay Health Care AUD 0.66 0.01 Dec/2025
Sonic Healthcare AUD 0.53 0.04 Dec/2025
Starpharma Holdings AUD 0 0.01 Dec/2025
Telix Pharmaceuticals AUD -0.05 0.33 Dec/2025